21. CHARACTERISTICS OF PATIENTS WITH PNEUMONIA CAUSED BY SARS - COV 2 TREATMENT AT THE RESPIRATORY DEPARTMENT OF THONG NHAT HOSPITAL

Nguyen Duy Cuong1, Ngo The Hoang1, Pham Minh Tri1, Phung Thao My1, Do Thanh Son1, Hoang Thai Duong1, Le Thi Diep1, Le Thi Quyen1
1 Thong Nhat Hospital

Main Article Content

Abstract

Objective: Study the characteristics of pneumonia caused by SARS-CoV-2 admitted to the Respiratory Department at Thong Nhat hospital.


Methods: Description, cross-sectional, case series. The study was conducted on 136 cases of confirmed pneumonia caused by SARS-CoV-2. Diagnosis of pneumonia caused by SARSCoV 2 was by chest X-ray and/or CT scan. Main results: SARS-CoV-2 pneumonia symptoms, clinical examination and blood tests, RT-PCR (reverse transcription polymerase chain reaction) results and chest X-ray results.


Results: There were 80 (58.8%) men and 56 (41.2%) women, average age was 68.2 ± 10.5 and BMI 26.7 ± 6.2 kg/m2. Under 60 years old accounted for 35.3%; 60-70 years old 22.1%; 71- 80 years old 23.5% and > 80 years old only 10.1%. Common comorbidities were hypertension 42.6%; diabetes 40.4%; chronic lung disease 22.8%. Time from onset to pneumonia was about 7.5 ± 2.1 days. The number of people with bilateral pneumonia accounted for 72.1%. Common symptoms were fever, cough, breathing difficulty, digestive disorders, muscle pain, weakness and headache. Oxygen saturation, CRP and white blood cell count in the bilateral pneumonia group were 92.1 ± 2.3%; 81.5 ± 32.3 mg/L and 9 ± 2.4 103/mm3, respectively; were statistically significantly different compared to the unilateral pneumonia group. The rate of respiratory failure/mechanical ventilation, pulmonary embolism complications, long hospital stay and mortality rate were mainly in the group with bilateral pneumonia.


Conclusion: Pneumonia caused by SARS-CoV-2 mainly has symptoms of fever, cough and breathing difficulty. Complications and death rates are high when bilateral pneumonia is present.

Article Details

References

[1] Zhu N, Zhang DY, et al (2020). A novel coronavirus from patients with pneumonia in China. N Engl J Med. pmid:31978945.
[2] Valencia DN (2020). Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2. Cureus; 12(3): e7386. pmid:32337113.
[3] World Health Organization (2021). COVID-19 Weekly Epidemiological Update.
[4] Guan WJ, Ni ZY, et al (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med; 28: 1-13.
[5] Huang C, Wang Y, et al (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. Lancet; 395:497-506.
[6] Zunyou W, Jennifer M.M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. Jama; 323 (13):1239-42.
[7] Gao Y, Li T, et al (2020). Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol
[Internet]; 92(7): 791-6.
[8] Rodriguez-Morales AJ, Cardona-Ospina JA, et al (2020). Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis; 34: 101623.
[9] Yang J, Zheng Y, et al (2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis;9 4: 91-5.
[10] Chen N, Zhou M, et al (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet; 395(10223): 507-13.
[11] Trần Văn Giang, Nguyễn Thị Ngọc (2021). Đặc điểm lâm sàng, cận lâm sàng của bệnh nhân viêm phổi do COVID-19 điều trị tại Bệnh viện Bệnh nhiệt đới TW. VMJ. 2021;1:348-51.
[12] OECD (2020). Realising the Potential of Primary Health Care. OECD; 1-16.
[13] A multi-centre study in Wenzhou city, Zhejiang China. J Infect. 2020; 80(4):388-93.
[14] Liu K, Chen Y, et al (2020). Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect;
80: e14-8.
[15] Niu S, Tian S, et al (2020). Clinical characteristics of older patients infected with COVID-19: A descriptive study. Arch GerontolGeriatr; 89:
104058.
[16] Wang D, Hu B, et al (2020). Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA; 2020: 1-9.
[17] Nabavi S, Allahyari A, et al (2021). Clinical features and disease severity in an Iranian population of inpatients with COVID-19. Scientific
Reports; 11(1): 1-9.
[18] Shi S, Qin M, et al (2020). Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan China. JAMA Cardiol; 25: e200950.
[19] Lê Tuấn Linh, Lê Thị Thùy Linh, và cs (2023). Nghiên cứu đặc điểm hình ảnh viêm phổi COVID-19 trên phim CLVT ngục và mối liên quan với mức độ bệnh. VMJ; 1: 232-36.
[20] Nguyễn V. Thắng., Hoàng V. H., và cs (2022). Đặc điểm hình ảnh và mối liên quan giữa điểm số trầm trọng của viêm phổi do covid- 19 trên phim chụp x quang, cắt lớp vi tính ngực với một số chỉ số lâm sàng. VMJ; 517.
[21] Zhang L, Zhu F, et al (2020). Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan China. Ann Oncol; 31(7): 894.